Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EP-101 Single-Dose Dose-Ranging Study in COPD
NCT02948582Phase 2Completed
- Sponsor
- Sunovion
- Start
- Jul 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD) (6 arms), sponsored by Sunovion. Primary endpoints: Trough Forced Expiratory Volume in 1 Second, Area Under the FEV1 Curve 0-12 Hours and 3 more. Started Jul 2010; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02948582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02948582.